{"entity":{"type":"insider","cik":"0001909636","url":"/insider/0001909636","json_url":"/insider/0001909636.json","name":"Swartz Robin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":16,"first":"2022-03-23","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Swartz Robin","source":"filing","n_filings":16,"first_seen":"2022-03-23","last_seen":"2026-02-26"}],"transactions":[{"id":6084975,"accession":"0001104659-26-020183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-020183","line_url":"/filing/0001104659-26-020183#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6458.0,"shares_display":"6,458","price_per_share":3.77,"price_display":"3.77","price_state":"stated","total_value":24346.66,"total_display":"24,346.66","total_whole":"24,347","shares_owned_after":199738.0,"shares_owned_after_display":"199,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":5768817,"accession":"0001104659-26-018131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-018131","line_url":"/filing/0001104659-26-018131#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3882.0,"shares_display":"3,882","price_per_share":3.44,"price_display":"3.44","price_state":"stated","total_value":13354.08,"total_display":"13,354.08","total_whole":"13,354","shares_owned_after":206196.0,"shares_owned_after_display":"206,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider"},{"id":5942432,"accession":"0001104659-26-013416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-013416","line_url":"/filing/0001104659-26-013416#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4569.0,"shares_display":"4,569","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":17590.65,"total_display":"17,590.65","total_whole":"17,591","shares_owned_after":210078.0,"shares_owned_after_display":"210,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-11","scope":"insider"},{"id":4724944,"accession":"0001104659-25-016516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-016516","line_url":"/filing/0001104659-25-016516#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3894.0,"shares_display":"3,894","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":16549.5,"total_display":"16,549.50","total_whole":"16,550","shares_owned_after":98397.0,"shares_owned_after_display":"98,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-24","scope":"insider"},{"id":4266904,"accession":"0001104659-25-012198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-012198","line_url":"/filing/0001104659-25-012198#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6950.0,"shares_display":"6,950","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":30927.5,"total_display":"30,927.50","total_whole":"30,928","shares_owned_after":102291.0,"shares_owned_after_display":"102,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-12","scope":"insider"},{"id":5083426,"accession":"0001104659-25-003773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-003773","line_url":"/filing/0001104659-25-003773#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (COO & CBO)","role_mark":"O","role_mark_label":"Officer (COO & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3087.0,"shares_display":"3,087","price_per_share":5.09,"price_display":"5.09","price_state":"stated","total_value":15712.83,"total_display":"15,712.83","total_whole":"15,713","shares_owned_after":109241.0,"shares_owned_after_display":"109,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-14","filed_date":"2025-01-15","scope":"insider"},{"id":2779828,"accession":"0001104659-24-131725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-131725","line_url":"/filing/0001104659-24-131725#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (COO&CBO)","role_mark":"O","role_mark_label":"Officer (COO&CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO&CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":5.65,"price_display":"5.65","price_state":"stated","total_value":36725.0,"total_display":"36,725.00","total_whole":"36,725","shares_owned_after":112328.0,"shares_owned_after_display":"112,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider"},{"id":3117354,"accession":"0001104659-24-043107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-043107","line_url":"/filing/0001104659-24-043107#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1357.0,"shares_display":"1,357","price_per_share":9.88,"price_display":"9.88","price_state":"stated","total_value":13407.16,"total_display":"13,407.16","total_whole":"13,407","shares_owned_after":117004.0,"shares_owned_after_display":"117,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":2875109,"accession":"0001104659-24-026562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-026562","line_url":"/filing/0001104659-24-026562#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3966.0,"shares_display":"3,966","price_per_share":7.45,"price_display":"7.45","price_state":"stated","total_value":29546.7,"total_display":"29,546.70","total_whole":"29,547","shares_owned_after":118361.0,"shares_owned_after_display":"118,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-22","scope":"insider"},{"id":3094498,"accession":"0001104659-24-005247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-005247","line_url":"/filing/0001104659-24-005247#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2543.0,"shares_display":"2,543","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":18182.45,"total_display":"18,182.45","total_whole":"18,182","shares_owned_after":72327.0,"shares_owned_after_display":"72,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":8429476,"accession":"0001104659-23-042228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-042228","line_url":"/filing/0001104659-23-042228#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1259.0,"shares_display":"1,259","price_per_share":7.83,"price_display":"7.83","price_state":"stated","total_value":9857.97,"total_display":"9,857.97","total_whole":"9,858","shares_owned_after":71617.0,"shares_owned_after_display":"71,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8429417,"accession":"0001104659-23-035640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-035640","line_url":"/filing/0001104659-23-035640#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3654.0,"shares_display":"3,654","price_per_share":7.76,"price_display":"7.76","price_state":"stated","total_value":28355.04,"total_display":"28,355.04","total_whole":"28,355","shares_owned_after":72876.0,"shares_owned_after_display":"72,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-22","scope":"insider"},{"id":8726107,"accession":"0001104659-23-033928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-033928","line_url":"/filing/0001104659-23-033928#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15373.0,"shares_display":"15,373","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":126058.6,"total_display":"126,058.60","total_whole":"126,059","shares_owned_after":76530.0,"shares_owned_after_display":"76,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-17","scope":"insider"},{"id":8014265,"accession":"0001104659-23-005049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-005049","line_url":"/filing/0001104659-23-005049","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2188.0,"shares_display":"2,188","price_per_share":9.84872029250457,"price_display":"9.85","price_state":"stated","total_value":21549.0,"total_display":"21,549.00","total_whole":"21,549","shares_owned_after":52695.0,"shares_owned_after_display":"52,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider","n_lines":2},{"id":6882985,"accession":"0001104659-22-043246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-043246","line_url":"/filing/0001104659-22-043246#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1527.0,"shares_display":"1,527","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":12597.75,"total_display":"12,597.75","total_whole":"12,598","shares_owned_after":52060.0,"shares_owned_after_display":"52,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-06","scope":"insider"},{"id":6990532,"accession":"0001104659-22-037154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-037154","line_url":"/filing/0001104659-22-037154","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001909636","owner_name":"Swartz Robin","owner_display_name":"Swartz Robin","owner_url":"/insider/0001909636","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4413.0,"shares_display":"4,413","price_per_share":8.294507138001359,"price_display":"8.29","price_state":"stated","total_value":36603.66,"total_display":"36,603.66","total_whole":"36,604","shares_owned_after":53638.0,"shares_owned_after_display":"53,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-23","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640266","name":"Voyager Therapeutics, Inc.","url":"/issuer/0001640266","role":"Officer (COO & CBO)","n_filings":16,"first_seen":"2022-03-23","last_seen":"2026-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001909636","retrieved_at":"2026-08-27T04:14:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}